Literature DB >> 7088002

Supermutagenicity of ethylnitrosourea in the mouse spot test: comparisons with methylnitrosourea and ethylnitrosourethane.

L B Russell, C S Montgomery.   

Abstract

The effects of the 3 related compounds ethylnitrosourea (ENU), methylnitrosourea (MNU), and ethylnitrosourethane (NEC) were studied in the mouse spot test. ENU induces a large number of recessive spots (RS) and, due to its low toxicity, can be applied at relatively high doses. This combination of properties makes it the most efficient spot-test mutagen, as shown in a comparison with 16 other chemicals, even though, on the basis of molarity, it is not the most potent one. The ENU mutation frequency in cells at risk, calculated per locus, per unit of applied dose, is roughly similar for melanocyte precursors (in the spot test) and spermatogonial stem cells (in the specific-locus test). MNU which, due to its high embryotoxicity, could be tested only at a low dose, is clearly mutagenic, and dose extrapolations indicate it to be more potent than ENU. NEC, though it could be tested at higher molarities than ENU, is only weakly mutagenic. The spot test, in addition to mutational data, also yields information on cytotoxicity (white midventral spots), embryotoxicity, and teratogenicity. The toxicity and teratogenicity findings parallel earlier results in the rat. For all endpoints studied. ENU is more effective than NEC. Relative to MNU, ENU is less toxic, less teratogenic, and less mutagenic in the spot test; but it is much more carcinogenic (transplacentally) and more mutagenic in spermatogonia. We propose that MNU is more effective in inducing gross chromosomal damage than is ENU, while ENU induces relatively more gene mutations. The spot test scores both types of mutational damage, while mostly the latter type is recovered from spermatogonia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7088002     DOI: 10.1016/0027-5107(82)90223-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Comparison of the genetic effects of equimolar doses of ENU and MNU: while the chemicals differ dramatically in their mutagenicity in stem-cell spermatogonia, both elicit very high mutation rates in differentiating spermatogonia.

Authors:  Liane B Russell; Patricia R Hunsicker; William L Russell
Journal:  Mutat Res       Date:  2006-12-14       Impact factor: 2.433

2.  Analysis of the MCMV resistome by ENU mutagenesis.

Authors:  Karine Crozat; Philippe Georgel; Sophie Rutschmann; Navjiwan Mann; Xin Du; Kasper Hoebe; Bruce Beutler
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

3.  ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.

Authors:  A R Moser; E M Mattes; W F Dove; M J Lindstrom; J D Haag; M N Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor.

Authors:  Daekee Lee; Sally H Cross; Karen E Strunk; Joanne E Morgan; Candice L Bailey; Ian J Jackson; David W Threadgill
Journal:  Mamm Genome       Date:  2004-07       Impact factor: 2.957

5.  The mouse spot test: results with a new cross.

Authors:  J Hart
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

6.  Estimating the number of coding mutations in genotypic- and phenotypic-driven N-ethyl-N-nitrosourea (ENU) screens.

Authors:  David A Keays; Taane G Clark; Jonathan Flint
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

7.  Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice.

Authors:  Dorothy Concepcion; Kevin L Seburn; Gen Wen; Wayne N Frankel; Bruce A Hamilton
Journal:  Genetics       Date:  2004-10       Impact factor: 4.402

8.  N-Ethyl-n-Nitrosourea Induced Leukaemia in a Mouse Model through Upregulation of Vascular Endothelial Growth Factor and Evading Apoptosis.

Authors:  Abdullahi Aliyu; Mohd Rosly Shaari; Nurul Syahirah Ahmad Sayuti; Mohd Farhan Hanif Reduan; Shanmugavelu Sithambaram; Mustapha Mohamed Noordin; Khozirah Shaari; Hazilawati Hamzah
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.